申请人:LILLY CO ELI
公开号:WO2001096296A1
公开(公告)日:2001-12-20
Compounds of formula (I) in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.